At least 17 states have launched such programs, and Connecticut, armed with $185 million in settlement funds, 22% of which ...
Phase 2 topline readout expected in Q4 2026 following patient follow-up, database lock, and unblinding POTOMAC, MD / ACCESS Newswire / August 17, 2026 / IGC Pharma, Inc. (NYSE American:IGC), a clinica ...